[How is the oral cavity affected by cancer treatment?].
Herlofson
Bente Brokstad
BB
Det odontologiske fakultet, Avdeling for oral kirurgi og oral medisin, Universitetet i Oslo, Postboks 1109 Blindern, 0317 Oslo. brokstad@odont.uio.no
Løken
Kristine
K
D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D009059:Mouth Diseases / Q000139:chemically induced / Q000209:etiology* / Q000473:pathology; D009061:Mouth Mucosa / Q000187:drug effects / Q000473:pathology / Q000528:radiation effects; D052016:Mucositis / Q000139:chemically induced / Q000209:etiology / Q000473:pathology; D010020:Osteonecrosis / Q000139:chemically induced / Q000473:pathology; D010025:Osteoradionecrosis / Q000209:etiology / Q000473:pathology; D011878:Radiotherapy / Q000009:adverse effects*; D012307:Risk Factors; D012469:Salivary Glands / Q000187:drug effects / Q000528:radiation effects; D014076:Tooth Diseases / Q000139:chemically induced / Q000209:etiology*
D000970:Antineoplastic Agents